Digestive & Intestinal Remedies (Pharmacies) - New Zealand

New Zealand

Highlights

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$6.76m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.83%, resulting in a market volume of US$7.78m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$1.28 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestive & Intestinal Remedies (Pharmacies) market in New Zealand has been experiencing steady growth in recent years.

Customer preferences: Customers in New Zealand have been increasingly seeking out digestive and intestinal remedies to address common health issues such as indigestion, bloating, and constipation. This trend can be attributed to several factors, including a growing awareness of the importance of gut health and an increasing emphasis on self-care and wellness. Additionally, the aging population in New Zealand has contributed to the demand for digestive and intestinal remedies, as older individuals are more prone to digestive issues.

Trends in the market: One notable trend in the Digestive & Intestinal Remedies (Pharmacies) market in New Zealand is the rising popularity of natural and herbal remedies. Consumers are increasingly opting for products that are perceived as more natural and gentle on the digestive system. This trend is in line with the global shift towards natural and organic products in the healthcare industry. As a result, pharmacies in New Zealand have been expanding their offerings of natural digestive and intestinal remedies to cater to this growing demand. Another trend in the market is the increasing availability of over-the-counter (OTC) digestive and intestinal remedies. Previously, many of these products required a prescription, but there has been a shift towards making them more accessible to consumers. This has been driven by regulatory changes and a growing recognition of the safety and efficacy of certain OTC remedies. The increased availability of these products has made it easier for consumers to address their digestive issues without the need for a doctor's visit.

Local special circumstances: New Zealand's unique geography and climate have also contributed to the development of the Digestive & Intestinal Remedies (Pharmacies) market. The country is known for its pristine natural environment and clean air, which has led to a strong focus on health and wellness among the population. Additionally, the prevalence of outdoor activities and a healthy lifestyle in New Zealand has further fueled the demand for digestive and intestinal remedies, as individuals seek to maintain optimal digestive health to support their active lifestyles.

Underlying macroeconomic factors: The overall growth of the Digestive & Intestinal Remedies (Pharmacies) market in New Zealand can be attributed to favorable macroeconomic factors. The country has experienced stable economic growth in recent years, which has translated into higher disposable incomes for consumers. This has allowed individuals to prioritize their health and well-being, leading to increased spending on healthcare products, including digestive and intestinal remedies. Furthermore, the government's focus on healthcare and wellness initiatives has also played a role in driving the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in New Zealand is experiencing growth due to customer preferences for natural remedies, the increasing availability of OTC products, the country's focus on health and wellness, and favorable macroeconomic factors. As the market continues to evolve, it is important for pharmacies to stay abreast of these trends and cater to the changing needs and preferences of consumers.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.